These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 698974)

  • 1. Human renal cell carcinoma as a hormone-dependent tumor.
    Concolino G; Marocchi A; Conti C; Tenaglia R; Di Silverio F; Bracci U
    Cancer Res; 1978 Nov; 38(11 Pt 2):4340-4. PubMed ID: 698974
    [No Abstract]   [Full Text] [Related]  

  • 2. Human endometrial cancer cell cultures for hormonal studies.
    Satyaswaroop PG; Fleming H; Bressler RS; Gurpide E
    Cancer Res; 1978 Nov; 38(11 Pt 2):4367-75. PubMed ID: 698977
    [No Abstract]   [Full Text] [Related]  

  • 3. Steroid hormones and endometrial cancer.
    Siiteri PK
    Cancer Res; 1978 Nov; 38(11 Pt 2):4360-6. PubMed ID: 359136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of the progesterone receptor in the estrogen-induced and -dependent renal tumor of the Syrian golden hamster.
    Li SA; Li JJ; Villee CA
    Ann N Y Acad Sci; 1977 Mar; 286():369-83. PubMed ID: 281185
    [No Abstract]   [Full Text] [Related]  

  • 5. Progestational therapy in human renal carcinoma and steroid receptors.
    Concolino G; Marocchi A; Di Silverio F; Conti C
    J Steroid Biochem; 1976; 7(11-12):923-7. PubMed ID: 1025371
    [No Abstract]   [Full Text] [Related]  

  • 6. Antagonistic action between cyclic adenosine 3':5'-monophosphate and estrogen in rat mammary tumor growth control.
    Cho-Chung YS
    Cancer Res; 1978 Nov; 38(11 Pt 2):4071-5. PubMed ID: 212186
    [No Abstract]   [Full Text] [Related]  

  • 7. Steroid receptors in human renal carcinoma.
    Chen L; Weiss FR; Chaichik S; Keydar I
    Isr J Med Sci; 1980 Nov; 16(11):756-60. PubMed ID: 7192273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor activation in relation to previous estrogen treatment in carcinoma corporis uteri heterotransplanted into nude mice.
    Horvath G; Fernö M; Cameron R; Ranstam J
    In Vivo; 1989; 3(2):93-7. PubMed ID: 2519844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular heterogeneity of cytosolic forms of estrogen receptors from human breast tumors.
    Kute TE; Heidemann P; Wittliff JL
    Cancer Res; 1978 Nov; 38(11 Pt 2):4307-13. PubMed ID: 698972
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of a slow-growing, transplantable rat mammary tumor (MCR-83): a model for endocrine-related cell kinetic studies.
    van Dierendonck JH; Cornelisse CJ; van der Linden PW; van Putten LM; van de Velde CJ
    Cancer Res; 1987 Aug; 47(15):4093-8. PubMed ID: 3607751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A relationship between estrogen sulfurylation and estrogen and progesterone receptor status in human mammary carcinoma.
    Pewnim T; Adams JB; Ho KP
    Cancer Res; 1980 Apr; 40(4):1360-2. PubMed ID: 6928401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progesterone therapy of endometrial cancer].
    Webb MJ
    Gynakologe; 1993 Apr; 26(2):118-22. PubMed ID: 8508980
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors.
    Kiss R; de Launoit Y; Danguy A; Paridaens R; Pasteels JL
    Cancer Res; 1989 Jun; 49(11):2945-51. PubMed ID: 2720654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of c-fos expression in estrogen-induced hamster renal tumors compared with kidney not due to creation of an estrogen-response element by point mutation in the gene's flanking sequence.
    Sarabia SF; Liehr JG
    Mol Carcinog; 1999 Apr; 24(4):255-62. PubMed ID: 10326862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical limitations of renal cell carcinoma preoperative embolization.
    Passariello R; Di Silverio F; Tenaglia R; Concolino G
    Ann Radiol (Paris); 1981; 24(5):426-7. PubMed ID: 7332227
    [No Abstract]   [Full Text] [Related]  

  • 16. Receptor profiles in renal cell carcinoma.
    Karr JP; Schneider S; Rosenthal H; Sandberg AA; Murphy GP
    Prog Clin Biol Res; 1982; 100():211-44. PubMed ID: 7145947
    [No Abstract]   [Full Text] [Related]  

  • 17. Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer.
    Kuo SH; Chen CL; Huang CS; Cheng AL
    Anticancer Res; 2000; 20(3B):2219-22. PubMed ID: 10928181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT.
    Isaacs JT; Heston WD; Weissman RM; Coffey DS
    Cancer Res; 1978 Nov; 38(11 Pt 2):4353-9. PubMed ID: 698976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
    De Maeyer L; Van Limbergen E; De Nys K; Moerman P; Pochet N; Hendrickx W; Wildiers H; Paridaens R; Smeets A; Christiaens MR; Vergote I; Leunen K; Amant F; Neven P
    J Clin Oncol; 2008 Jan; 26(2):335-6; author reply 336-8. PubMed ID: 18182677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.